Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

Cellebrite DI Ltd
NASDAQ:CLBT

Watchlist Manager
Cellebrite DI Ltd Logo
Cellebrite DI Ltd
NASDAQ:CLBT
Watchlist
Price: 11.61 USD -1.78% Market Closed
Market Cap: $2.9B
Write Note Create Alert Ask AI

Wall St Price Targets

CLBT Price Targets Summary
Cellebrite DI Ltd

Wall Street analysts forecast CLBT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLBT is 15.3 USD with a low forecast of 12.63 USD and a high forecast of 21.43 USD.

CLBT Lowest Forecast
Wall Street Target
$12.63
9% Upside
CLBT Average Forecast
Wall Street Target
$15.3
32% Upside
CLBT Highest Forecast
Wall Street Target
$21.43
85% Upside
Lowest Forecast
Price Target
12.63 USD
9% Upside
Average Forecast
Price Target
15.3 USD
32% Upside
Highest Forecast
Price Target
21.43 USD
85% Upside
Cellebrite DI Ltd Competitors:
Price Targets

Revenue
Forecast

20% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
20% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 5 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 4 years is 17%.

What are analyst estimates?

Gross Profit
Forecast

21% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
21% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 5 years, the compound annual growth rate for Gross Profit has been 21%. The projected CAGR for the next 4 years is 17%.

What are analyst estimates?

Operating Income
Forecast

49% / Year
Past Growth
39% / Year
Estimated Growth
Estimates Accuracy
-38%
Average Miss
49% / Year
Past Growth
39% / Year
Estimated Growth
Estimates Accuracy
-38%
Average Miss

Over the last 5 years, the compound annual growth rate for Operating Income has been 49%. The projected CAGR for the next 4 years is 39%.

What are analyst estimates?

Pre-Tax Income
Forecast

51% / Year
Past Growth
38% / Year
Estimated Growth
Estimates Accuracy
20%
Average Beat
51% / Year
Past Growth
38% / Year
Estimated Growth
Estimates Accuracy
20%
Average Beat

Over the last 5 years, the compound annual growth rate for Pre-Tax Income has been 51%. The projected CAGR for the next 3 years is 38%.

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
40% / Year
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
40% / Year
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Net Income over the next 3 years is 40%.

What are analyst estimates?

Continue CLBT Research

Summary
CLBT intrinsic value, competitors valuation, and company profile.
DCF Valuation
CLBT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CLBT stock valuation using valuation multiples.
Wall St Estimates
CLBT price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CLBT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Cellebrite DI Ltd listings:
F • EUR
9W9
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CLBT's stock price target?
Price Target
15.3 USD

According to Wall Street analysts, the average 1-year price target for CLBT is 15.3 USD with a low forecast of 12.63 USD and a high forecast of 21.43 USD.

What is the Revenue forecast for Cellebrite DI Ltd?
Projected CAGR
17%

Over the last 5 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 4 years is 17%.

What is the Gross Profit forecast for Cellebrite DI Ltd?
Projected CAGR
17%

Over the last 5 years, the compound annual growth rate for Gross Profit has been 21%. The projected CAGR for the next 4 years is 17%.

What is the Operating Income forecast for Cellebrite DI Ltd?
Projected CAGR
39%

Over the last 5 years, the compound annual growth rate for Operating Income has been 49%. The projected CAGR for the next 4 years is 39%.

What is the Pre-Tax Income forecast for Cellebrite DI Ltd?
Projected CAGR
38%

Over the last 5 years, the compound annual growth rate for Pre-Tax Income has been 51%. The projected CAGR for the next 3 years is 38%.

What is the Net Income forecast for Cellebrite DI Ltd?
Projected CAGR
40%

The compound annual growth rate for Net Income over the next 3 years is 40%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.